Cargando…
Identification of a novel gene signature for the prediction of recurrence in HCC patients by machine learning of genome-wide databases
Hepatocellular carcinoma (HCC) is a common malignant tumor in China. In the present study, we aimed to construct and verify a prediction model of recurrence in HCC patients using databases (TCGA, AMC and Inserm) and machine learning methods and obtain the gene signature that could predict early rela...
Autores principales: | Shen, Jie, Qi, Liang, Zou, Zhengyun, Du, Juan, Kong, Weiwei, Zhao, Lianjun, Wei, Jia, Lin, Ling, Ren, Min, Liu, Baorui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064516/ https://www.ncbi.nlm.nih.gov/pubmed/32157118 http://dx.doi.org/10.1038/s41598-020-61298-3 |
Ejemplares similares
-
The Efficacy and Safety of Hypofractionated Radiation Therapy With Tomotherapy for Advanced or Recurrent Hepatocellular Carcinoma
por: Shen, Jie, et al.
Publicado: (2021) -
Therapeutic effect and safety of individualized chemotherapy combined with sequential immunotherapy based on BRCA1 mRNA expression level in unresectable pancreatic cancer
por: Du, Juan, et al.
Publicado: (2022) -
A novel signature based on microvascular invasion predicts the recurrence of HCC
por: Du, Binbin, et al.
Publicado: (2020) -
Advanced HCC Patient Benefit From Neoantigen Reactive T Cells Based Immunotherapy: A Case Report
por: Liu, Chenxi, et al.
Publicado: (2021) -
Decoding Immune Signature to Detect the Risk for Early-Stage HCC Recurrence
por: Devan, Aswathy R., et al.
Publicado: (2023)